Dr. Essien is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Broad Street
Philadelphia, PA 19140
Summary
- Dr. Eno-Obong Essien is a pulmonologist specializing in critical care medicine, based in Philadelphia, PA. She completed her medical degree at the University of Maryland School of Medicine in 2017, followed by a residency in internal medicine at Temple University Hospital from 2017 to 2020, and a fellowship in pulmonary disease and critical care medicine at the University of Pennsylvania Health System from 2020 to 2023. Her research focuses on nanoparticle applications and inflammatory responses in pulmonary contexts, with publications in notable journals such as ACS Nano and Advanced Materials.
Education & Training
University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 2020 - 2023
Temple University HospitalResidency, Internal Medicine, 2017 - 2020
University of Maryland School of MedicineClass of 2017
Certifications & Licensure
PA State Medical License Active through 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial System.Marco E Zamora, Eno-Obong Essien, Kartik Bhamidipati, Aditi Murthy, Jing Liu
ACS Nano. 2024-08-20 - 13 citationsPhysicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions.Serena Omo-Lamai, Marco E Zamora, Manthan N Patel, Jichuan Wu, Jia Nong
Advanced Materials. 2024-06-01 - 3 citationsLipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side Effects.Serena Omo-Lamai, Yufei Wang, Manthan N Patel, Eno-Obong Essien, Mengwen Shen
Biorxiv. 2024-04-18
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
